Article info

Download PDFPDF
Using a biomarker acutely to identify babies at risk of serious adverse effects from antibiotics: where is the ‘Terrible Moral and Medical Dilemma’?

Authors

  • Anneke M Lucassen CELS, University of Southampton, Southampton, UK PubMed articlesGoogle scholar articles
  • John Henry McDermott Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK Division of Evolution & Genomic Sciences, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • William Newman Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK Division of Evolution & Genomic Sciences, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Anneke M Lucassen, Clinical Ethics and Law (CELS), Faculty of Medicine, University of Southampton and Wessex Clinical Genetics Service, Southampton SO17 1BJ, UK; a.m.lucassen{at}soton.ac.uk
View Full Text

Citation

Lucassen AM, McDermott JH, Newman W
Using a biomarker acutely to identify babies at risk of serious adverse effects from antibiotics: where is the ‘Terrible Moral and Medical Dilemma’?

Publication history

  • Received November 2, 2020
  • Revised November 24, 2020
  • Accepted November 29, 2020
  • First published December 17, 2020.
Online issue publication 
January 22, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Other content recommended for you